T1 - High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to ... High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to ... High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to ... High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to ...
... to assess the incidence and analyze reasons which cause prolongation of hospital stay in patients engrafted after peripheral ... blood stem cell transplantation (PBSCT), we performed this retrospective analysis. One hundred patients (receiving 123 ... Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation ... Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. A ...
Less than 5-7% of germ cells occur outside the gonads, but of the extragonadal sites, the mediastinum is the most common ... Germ cell tumors of the mediastinum are uncommon. ... High-Dose Chemotherapy and Autologous Peripheral-Blood Stem- ... Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University Experience. J Clin Oncol. 2017 Apr 1. 35 ... Germ cell tumors of the mediastinum are uncommon. Fewer than 5-7% of germ cell tumors occur outside the gonads, but of the ...
Intensive or high-dose chemotherapy with autologous bone marrow transplantation or peripheral blood stem cell rescue has not ... By nature, these tumors invade diffusely throughout the brain stem, growing between normal nerve cells. Aggressive surgery ... Hall WA, Doolittle ND, Daman M, Bruns PK, Muldoon L, Fortin D, Neuwelt EA (May 2006). "Osmotic blood-brain barrier disruption ... DMG is believed to be caused by genetic mutations that cause epigenetic changes in cells of the developing nervous system, ...
Thereafter, the patient received autologous peripheral blood stem cell transplantation with high-dose chemotherapy (combination ... Secondary chronic myelogenous leukemia after autologous peripheral blood stem cell transplantation for lymphoma. Int J Hematol ... Treatment-related malignant blood diseases are known to include acute myelocytic leukemia and myelodysplastic syndrome, but ... An increase in the peripheral leukocyte count was noted 56 months after the diagnosis of MFH was made. Cytogenetic study showed ...
High-dose melphalan followed by autologous peripheral blood stem cell transplantation may also be used. ... Autologous peripheral blood stem cell transplantation Hematopoietic Stem Cell Transplantation Hematopoietic stem cell (HSC) ... especially after autologous stem cell transplantation Hematopoietic Stem Cell Transplantation Hematopoietic stem cell (HSC) ... packed red blood cells are transfused Red blood cells (RBCs) Whole blood can provide improved oxygen-carrying capacity, volume ...
Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation ... Swiss Blood Stem Cell Transplantation Group), Haematopoietic stem cell transplantation: activity in Switzerland compared with ... for the Swiss Blood Stem Cell Transplantation Group (SBST), Haematopoietic cell transplantation in Switzerland, changes and ... High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem ...
T-cell lymphoma occurring four months after autologous peripheral blood stem cell transplantation with high-dose chemotherapy ... Peripheral blood polyclonal plasmacytosis mimicking plasma cell leukemia in patients with angioimmunoblastic T-cell lymphoma: ... Retrospective analysis of non-anaplastic peripheral T-cell lymphoma in pediatric patients in Japan. Pediatr Blood Cancer 2010; ... Pediatric T-cell post-transplant lymphoproliferative disorder after solid organ transplantation. Pediatr Blood Cancer 2008;50: ...
Treatment recommendations for patients with diffuse large B-cell lymphoma (DLBCL) begin with evaluating the extent of the ... and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas. Eur J Haematol. ... Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients ... Relapse patients eligible for high-dose chemotherapy (HDC) and autologous stem cell transplantation (ASCT): ...
Journal of Stem Cell Research and Transplantation - Téléchargez le document au format PDF ou consultez-le gratuitement en ligne ... during high-dose chemotherapy and autologous peripheral blood stem cell transplantation for patients aged 60 years and older. ... Incidence of supraventricular arrhythmias during autologous peripheral blood stem cell transplantation. Biol Blood Marrow ... Incidence of supraventricular arrhythmias during autologous peripheral blood stem cell transplantation. Biol Blood Marrow ...
... highly proliferative MM relapsing after high-dose chemotherapy and autologous peripheral blood stem cell transplantation. ELISA ... K562-mb15-41BBL cells expand natural killer cells, but not T-cells. Peripheral blood mononuclear cells from both HD (n=15) and ... 1 Significant advances have been made by combining novel agents with autologous peripheral blood stem cell transplantation ... effective in preventing relapse after haplo-identical T-cell-depleted allogeneic peripheral blood stem cell transplantation in ...
Stem cell mobilization dosing for Aphexda (motixafortide), frequency-based adverse effects, comprehensive interactions, ... to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in ... Monitor white blood cell counts during use. Potential for tumor cell mobilization *When used in combination with filgrastim for ... Tumor cell mobilization in patients with leukemia *When used for hematopoietic stem cell (HSC) mobilization, motixafortide may ...
CD patients maintained high remission rates for 3-24 months after transplantation. Stem cell transplantation is a valuable ... stem cell transplantation reduced the CD activity index (SMD − 2.10, P = 0.000), the CD endoscopic index of severity (SMD − ... the disease activity index dramatically decreased in the mesenchymal stem cell (MSC) treatment groups compared to the control ... We explored whether stem cell therapy was effective for animal models and patients with Crohns disease (CD). We ...
The patient then underwent high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation (auto-PBSCT ... The patient then underwent high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation (auto-PBSCT ... The patient then underwent high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation (auto-PBSCT ... The patient then underwent high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation (auto-PBSCT ...
High-dose melphalan followed by autologous peripheral blood stem cell transplantation may also be used. ... Autologous peripheral blood stem cell transplantation Hematopoietic Stem Cell Transplantation Hematopoietic stem cell (HSC) ... especially after autologous stem cell transplantation Hematopoietic Stem Cell Transplantation Hematopoietic stem cell (HSC) ... packed red blood cells are transfused Red blood cells (RBCs) Whole blood can provide improved oxygen-carrying capacity, volume ...
High Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myeloma. Sang-Byung ...
High Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myeloma. Sang-Byung ...
Then, high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation (auto-PBSCT) was initiated. ... Autologous peripheral blood stem cell transplantation (ASCT) was performed, followed by intravenous busulfan (ivBU), ... of global longitudinal strain following high-dose chemotherapy and autologous peripheral blood stem cell transplantation in ... Intravenous busulfan-based conditioning with autologous stem cell transplantation for refractory B-cell lymphoma with central ...
... as a Conditioning Regimen in Patients with Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Transplantation: ... as a Conditioning Regimen in Patients with Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Transplantation: ... as a Conditioning Regimen in Patients with Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Transplantation: ... as a Conditioning Regimen in Patients with Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Transplantation: ...
... they received intensive chemotherapy and high-dose chemotherapy with autologous peripheral blood stem cell transplantation ( ... and use of high-dose chemotherapy and autologous stem cell transplantation (HDT-ASCT) represent important factors associated ... Long-term Outcomes in Primary CNS Lymphoma After R-MVP and High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell ... 65â years for autologous stem-cell transplantation, and 70â years for the last clinical trials. Current therapeutic options ...
Treatment recommendations for patients with diffuse large B-cell lymphoma (DLBCL) begin with evaluating the extent of the ... and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas. Eur J Haematol. ... Relapse patients eligible for high-dose chemotherapy (HDC) and autologous stem cell transplantation (ASCT): ... Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse ...
The feasibility of neoadjuvant high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients ... High-Dose Chemotherapy with Autologous Stem Cell Support: High-dose chemotherapy with autologous stem cell support, also ... including hematopoietic stem cells (immature blood cells). A hematopoietic stem cell transplant replaces the stem cells that ... An autologous hematopoietic stem cell transplant makes use of a patients own stem cells. The stem cells are collected prior to ...
... therapeutic options have failed in SM but high-dose therapy followed by autologous peripheral blood stem cell transplantation ( ... The 72-h treatment with GNFs increased micronucleated cells at four doses (lowest 10 mu g/cm(2)). No dose-dependent effects ... GNFs increased DNA damage at all doses in the 24-h treatment, at two doses (40 and 100 mu g/cm(2)) in the 48-h treatment (dose- ... The 48-h treatment caused a significant increase in micronucleated cells at three doses (lowest 10 mu g/cm(2)) of CNTs and at ...
High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment. ... See Figure 5.Gadski, R. In vivo, however, these additional factors affect the ability of a drug to enter cells. ... Leukocyte-induced coats of glycosaminoglycan increase the resistance of glioma cells to cellular immune attack. Physiology and ... blood glucose level. The surgeon should ensure that the patient is given all the information necessary yajaha allow proper ...
... all three patients received high-dose chemotherapy followed by hematopoietic stem cell transplantation. Although the relapsed ... High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival ... Subsequently, each patient underwent high-dose chemotherapy followed by hematopoietic stem cell transplantation (HSCT). George ... was performed followed by autologous peripheral blood stem cell transplantation (auto-PBSCT). Unfortunately, the treatment ...
Salvage high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with relapsed or ... dose chemotherapy and autologous peripheral blood stem stem cell tumors in relapsed/refractory testicular germ cell tumors cell ... Autologous stem cell transplantation and complications, a practical approach. Eurasia Stem Cell Transplantation and Apheresis ... Autologous stem cell transplantation (SCN) in multiple myeloma, nonmyeloablative allogeneic stem cell transplantation (NST), ...
... "autologous peripheral stem cell transplantation". In this regard, the essential hematopoietic stem cells are removed, whilst ... The procedures that are on offer in such cases also include high-dose treatment with hematopoietic stem cell transplantation, ... Specialty in the field of haematology: An expert in blood. An important focal point of Professor Graevens range of services is ... For example, they often use high-dose chemotherapy with special hematopoietic stem cell transplantation. The chief physician ...
Patients underwent dose-intense immune suppression and autologous haemopoietic stem-cell (CD34) infusion. Peripheral blood ... Patients underwent dose-intense immune suppression and autologous haemopoietic stem-cell (CD34) infusion. Peripheral blood ... Patients underwent dose-intense immune suppression and autologous haemopoietic stem-cell (CD34) infusion. Peripheral blood ... Patients underwent dose-intense immune suppression and autologous haemopoietic stem-cell (CD34) infusion. Peripheral blood ...
... precision cancer medicines and or stem cell transplant in selected situations. The specific treatment depends on the stage of ... with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for ... The bodys normal cells that are most sensitive to destruction by high-dose therapy are the blood-producing stem cells in the ... High Dose Chemotherapy & Autologous Stem Cell Transplant. High-dose chemotherapy (HDC) is a standard treatment for the majority ...